AI assistant
PFIZER INC — Director's Dealing 2015
Feb 28, 2015
29831_dirs_2015-02-27_9cda75c5-ef18-425d-bb8f-2812e44a885c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2015-02-25
Reporting Person: LANKLER DOUGLAS M (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-02-25 | Common Stock | M | 32855.0000 | $17.6900 | Acquired | 141441.0000 | Direct |
| 2015-02-25 | Common Stock | A | 5432.0000 | $0.0000 | Acquired | 146873.0000 | Direct |
| 2015-02-25 | Common Stock | F | 2009.0000 | $34.6600 | Disposed | 144864.0000 | Direct |
| 2015-02-25 | Common Stock | F | 8504.0000 | $34.6600 | Disposed | 136360.0000 | Direct |
| 2015-02-25 | Common Stock | F | 12947.0000 | $33.4700 | Disposed | 123413.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-02-25 | Stock Appreciation Rights | $17.6900 | M | 32855.0000 | Disposed | 2015-02-25 | Common Stock (32855.0000) | Direct |
| 2015-02-26 | Stock Appreciation Rights | $34.5900 | A | 88567.0000 | Acquired | 2020-02-26 | Common Stock (88567.0000) | Direct |
| 2015-02-26 | Stock Appreciation Rights | $34.5900 | A | 73826.0000 | Acquired | 2022-02-26 | Common Stock (73826.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1305.0000 | Indirect |
Footnotes
F1: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
F2: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon).
F3: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon).
F4: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
F5: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
F6: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
F7: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
F8: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.